Cell Counting Market Size & Share 2024 - 2032
Market Size by Product Type (Instruments [Hemocytometers, Automated Cell Counters, Hematology Analyzers], Consumable & Reagents), Application (Complete Blood Count, Cell-based Therapies, Toxicity), End User & Forecast.
Report ID: GMI8496
|
Published Date: March 2024
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Cell Counting Market Size
Cell Counting Market size was valued at over USD 11.6 billion in 2023 and is expected to reach over USD 20.6 billion by 2032 due to the increasing incidence of chronic diseases, such as HIV, measles, diphtheria, cancer, and blood disorders. Healthcare providers are actively utilizing cell counting technologies to diagnose and monitor these conditions.
Cell Counting Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The ongoing prevalence of chronic diseases is driving the progression of medical advancements. Additionally, the continuous R&D efforts are making way for more accurate and efficient cell counting techniques, fueling the market expansion. For instance, in November 2023, HIV.gov. published a report stating that approximately 39 million people globally were living with HIV, with 1.3 million new infections in 2022. These figures are emphasizing the importance of precise cell counting and diagnostic tests in combating the spread of HIV.
Of late, academic institutions, research organizations, and industry players are collaborating and partnering to develop innovative cell counting solutions. They are pooling their resources, sharing expertise, and leveraging technologies to advance the field. These collaborations are driving breakthroughs in cell counting techniques and leading to more accurate and efficient methods for researchers.
With stakeholders in the market working together to push the boundaries of technology and developing cutting-edge solutions that meet the evolving needs of scientific research, the market will record steady growth. For instance, in May 2024, Galapagos and Adaptimmune initiated a clinical collaboration by potentially integrating cell counting technologies. This partnership aimed to develop innovative solutions, such as uza-cel, for head and neck cancer and other solid tumor indications, further marking a significant stride in advancing cell-based therapies.
On the other side, ethical considerations are hindering practices in the cell counting industry and necessitating responsible approaches to technology implementation. Simultaneously, a shortage of skilled personnel trained in operating and interpreting data will remain a constraint. However, the ongoing efforts on enhancing the ethical standards and expanding training programs to meet the future demands in the field may add positive impetus to the market growth.
Cell Counting Market Trends
Technological advancements in techniques, such as flow cytometry and automated hematology analyzers for improving accuracy and efficiency will play a key role in the market growth. These innovations are enabling researchers to obtain more precise and reliable cell counts for enhancing their ability to analyze samples and conduct experiments effectively. As technology continues to evolve, these techniques will further enhance to offer even greater accuracy and efficiency in cell counting processes. This ongoing refinement ensures that researchers can rely on cutting-edge tools to meet the demands of increasingly complex scientific inquiries in the future. For instance, in August 2022, DeNovix Inc announced the development of two dedicated nuclei counting apps that distinguish isolated nuclei and intact cells from debris.
Cell Counting Market Analysis
Based on product type, the market size from the consumables and reagents segment is poised to expand at 6.7% CAGR through 2032, fueled by the rising demand for essential materials in cell counting procedures. Consumables and reagents are continuing to play a pivotal role in providing the necessary tools for accurate cell analysis. As technological advancements are persisting, there have been product innovations. Future developments in cell counting methodologies and applications will further sustain the demand for consumables and reagents to ensure continuous growth.
Based on application, the cell counting market is classified into complete blood count, cell-based therapies, bioprocessing, toxicity, and other applications. The complete blood count segment is estimated to record 6.2% CAGR from 2024 to 2032. This is due to the rising prevalence of blood disorders like anemia and leukemia coupled with the widespread need for complete blood count in monitoring such conditions. For instance, in July 2022, MicroBioSensor introduced QUICKCHECK, a collaborative effort with Smallfry for offering a rapid and portable leukocyte count test device. The rising imperative to retrieve critical information about the health and functioning of various components of the blood will drive the segment expansion.
In terms of end-use, the hospital segment of the cell counting market is set to cross USD 5.8 billion by 2032. This can be attributed to the rising adoption of advanced cell counting technologies to enhance diagnostic and research capabilities. Hospitals are integrating automated cell counters and other innovative tools into their laboratories for enabling efficient analysis of patient samples. This factor is expected to continue as hospitals prioritize accurate and timely cell counting for various medical applications. The focus on embracing cutting-edge solutions, driven by the need for precise cell analysis in disease diagnosis, treatment monitoring, and personalized medicine to ensure ongoing advancements in healthcare delivery will favor the segment growth.
North America cell counting market size is expected to record over USD 7.7 billion by 2032 due to the rising investments in healthcare infrastructure and escalating R&D activities. These investments are bolstering the adoption of advanced cell counting technologies across various healthcare facilities and research institutions. This trend is expected to persist, driven by ongoing investments and the continuous focus on advancing healthcare technologies. Rising innovations in cell counting methodologies and tools will also strengthen North America's position as a key player in the global market.
Cell Counting Market Share
Key players in the industry are driving innovation through R&D efforts to gain competitive edges. They are also continuing to shape the industry landscape by fostering competition and advancing technology to meet the evolving customer needs.
Cell Counting Market Companies
Prominent players operating in the cell counting industry are as mentioned below:
Cell Counting Industry News
The cell counting market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 - 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product Type
Market, By Application
Market, By End-user
The above information has been provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →